213 related articles for article (PubMed ID: 36964823)
1. Cannabidiol Recovers Dopaminergic Neuronal Damage Induced by Reserpine or α-synuclein in Caenorhabditis elegans.
da Cruz Guedes E; Erustes AG; Leão AHFF; Carneiro CA; Abílio VC; Zuardi AW; Hallak JEC; Crippa JA; Bincoletto C; Smaili SS; Reckziegel P; Pereira GJS
Neurochem Res; 2023 Aug; 48(8):2390-2405. PubMed ID: 36964823
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and α-synuclein accumulation in C. elegans models of Parkinson's disease.
Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
Neurotoxicology; 2022 Dec; 93():128-139. PubMed ID: 36108815
[TBL] [Abstract][Full Text] [Related]
3. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
Zhu FD; Wang BD; Qin DL; Su XH; Yu L; Wu JM; Law BY; Guo MS; Yu CL; Zhou XG; Wu AG
CNS Neurosci Ther; 2024 Apr; 30(4):e14515. PubMed ID: 37905594
[TBL] [Abstract][Full Text] [Related]
4. Extracellular dopamine and alterations on dopamine transporter are related to reserpine toxicity in Caenorhabditis elegans.
Reckziegel P; Chen P; Caito S; Gubert P; Soares FA; Fachinetto R; Aschner M
Arch Toxicol; 2016 Mar; 90(3):633-45. PubMed ID: 25579234
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol regulates CB1-pSTAT3 signaling for neurite outgrowth, prolongs lifespan, and improves health span in Caenorhabditis elegans of Aβ pathology models.
Wang Z; Zheng P; Xie Y; Chen X; Solowij N; Green K; Chew YL; Huang XF
FASEB J; 2021 May; 35(5):e21537. PubMed ID: 33817834
[TBL] [Abstract][Full Text] [Related]
6. NCEH-1 modulates cholesterol metabolism and protects against α-synuclein toxicity in a C. elegans model of Parkinson's disease.
Zhang S; Glukhova SA; Caldwell KA; Caldwell GA
Hum Mol Genet; 2017 Oct; 26(19):3823-3836. PubMed ID: 28934392
[TBL] [Abstract][Full Text] [Related]
7. Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans.
Cheon SM; Jang I; Lee MH; Kim DK; Jeon H; Cha DS
Pharm Biol; 2017 Dec; 55(1):481-486. PubMed ID: 27937005
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease.
Harrington AJ; Yacoubian TA; Slone SR; Caldwell KA; Caldwell GA
J Neurosci; 2012 Feb; 32(6):2142-53. PubMed ID: 22323726
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling.
Kautu BB; Carrasquilla A; Hicks ML; Caldwell KA; Caldwell GA
Neurosci Lett; 2013 Apr; 541():116-9. PubMed ID: 23485787
[TBL] [Abstract][Full Text] [Related]
10. Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.
Yan J; Yang Z; Zhao N; Li Z; Cao X
BMC Neurosci; 2019 Jun; 20(1):31. PubMed ID: 31208386
[TBL] [Abstract][Full Text] [Related]
11. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
[TBL] [Abstract][Full Text] [Related]
12. Ferulic Acid Exerts Neuroprotective Effects via Autophagy Induction in
Long T; Wu Q; Wei J; Tang Y; He YN; He CL; Chen X; Yu L; Yu CL; Law BY; Wu JM; Qin DL; Wu AG; Zhou XG
Oxid Med Cell Longev; 2022; 2022():3723567. PubMed ID: 35242276
[TBL] [Abstract][Full Text] [Related]
13. N-γ-(L-glutamyl)-L-selenomethionine shows neuroprotective effects against Parkinson's disease associated with SKN-1/Nrf2 and TRXR-1 in Caenorhabditis elegans.
Chang CH; Wei CC; Ho CT; Liao VH
Phytomedicine; 2021 Nov; 92():153733. PubMed ID: 34537465
[TBL] [Abstract][Full Text] [Related]
14. 2-Butoxytetrahydrofuran, Isolated from
Promtang S; Sanguanphun T; Chalorak P; Pe LS; Niamnont N; Sobhon P; Meemon K
ACS Chem Neurosci; 2024 Jun; 15(11):2182-2197. PubMed ID: 38726817
[TBL] [Abstract][Full Text] [Related]
15. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
[TBL] [Abstract][Full Text] [Related]
16. Anti-Parkinsonian effects of β-amyrin are regulated via LGG-1 involved autophagy pathway in Caenorhabditis elegans.
Wei CC; Chang CH; Liao VH
Phytomedicine; 2017 Dec; 36():118-125. PubMed ID: 29157804
[TBL] [Abstract][Full Text] [Related]
17. Alpha-linolenic acid suppresses dopaminergic neurodegeneration induced by 6-OHDA in C. elegans.
Shashikumar S; Pradeep H; Chinnu S; Rajini PS; Rajanikant GK
Physiol Behav; 2015 Nov; 151():563-9. PubMed ID: 26300470
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
[TBL] [Abstract][Full Text] [Related]
19. Anti-Parkinson activity of bioactive substances extracted from Holothuria leucospilota.
Malaiwong N; Chalorak P; Jattujan P; Manohong P; Niamnont N; Suphamungmee W; Sobhon P; Meemon K
Biomed Pharmacother; 2019 Jan; 109():1967-1977. PubMed ID: 30551452
[TBL] [Abstract][Full Text] [Related]
20. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.
Jadiya P; Khan A; Sammi SR; Kaur S; Mir SS; Nazir A
Biochem Biophys Res Commun; 2011 Oct; 413(4):605-10. PubMed ID: 21925152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
